Jan 08 (Reuters) - AngioDynamics Q2 gross margin 54.8%.
Q2 net income USD -10.7 million
Q2 sales USD 73 million
Q2 adjusted EBITDA USD 3.1 million
Q2 adjusted net income USD -1.7 million
outlook FY sales USD 282-288 million
outlook FY gross margin 52-53%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.